TMEM178B: A Potential Drug Target and Biomarker (G100507421)

Target Name: TMEM178B

NCBI ID: G100507421

TMEM178B

Other Name(s): LOC100129514 | T178B_HUMAN | transmembrane protein 178B | hypothetical protein LOC100129514 | Transmembrane protein 178B

TMEM178B: A Potential Drug Target and Biomarker

TMEM178B, also known as heat shock protein 90 (Hsp90), is a protein that is expressed in various tissues and cells throughout the body. It is a heat shock protein, which means that it is produced in high levels when the body is subjected to heat stress, such as exercise or infection.

TMEM178B has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique expression patterns and functions make it an attractive target for researchers to study and develop new treatments.

One of the key reasons why TMEM178B has potential as a drug target is its unique expression patterns. Unlike many other proteins, TMEM178B is not expressed in all cells and tissues in the body. Instead, it is mainly expressed in the brain, heart, and lungs, which are known as the central nervous system (CNS) and the cardiovascular system (CVS). This makes it an attractive target for drugs that can modulate its expression and activity in these specific tissues and organs.

Another reason why TMEM178B is a promising biomarker is its ability to participate in various signaling pathways in the body. For example, TMEM178B has been shown to be involved in the production of reactive oxygen species (ROS), which can damage cellular components and contribute to the development of various diseases, including cancer.

In addition, TMEM178B has also been shown to play a role in the regulation of cellular signaling pathways that are involved in cell growth, differentiation, and survival. This makes it an attractive target for drugs that can modulate its activity and contribute to the development of cancer and other diseases.

The expression patterns and functions of TMEM178B make it an attractive target for drugs that can modulate its activity and contribute to the development of various diseases.

Overall, TMEM178B is a promising drug target and biomarker that has the potential to contribute to the development of new treatments for a variety of diseases. Further research is needed to fully understand its functions and potential as a drug target.

Protein Name: Transmembrane Protein 178B

The "TMEM178B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM178B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets